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1. Introduction 
Several types of nucleoside triphosphate-protein 
phosphotransferases (protein kinases, PK) activities 
have been recognized in various mammalian tissues 
[ 1 ]. These activities may be classified according to 
their dependence upon specific effectors [2] such as 
cyclic nucleotides (CAMP or cGMP), calcium and 
cahnodulin or ds RNA [2]. On the other hand, a 
number of PK activities have been characterized for 
which no specific effector has yet been demonstrated 
[ 1,2]; these activities may thus be termed messenger- 
independent protein kinases [2]. We had isolated in 
bovine adrenal cortex cytosol4 casein kinases belong- 
ing to this category [3]. These enzymatic moieties 
could be classified into an A-type casein kinase (using 
only ATP as phosphate donor, CKA) and a G-type 
(CKG, using GTP as well as ATP). The CKG activity 
was then shown to be in an inhibited form in crude 
tissue extract, due to the presence of a specific endog- 
enous in~bito~ factor (CKG I) isolated in homog- 
eneous form f43. In addition, it was found that poly- 
cations such as naturally occuring polyamines can 
stimulate purified CKG activity [3] and also release 
the CKG I inhibitory effect on the enzyme [S]. Poly- 
amines (e.g., spermine) were thus suggested as possi- 
ble mediators of the intracellular CKG-CKGI system 
t51. 
In the course of these studies, it was observed that 
glycosamino glycan structures such as heparin can 
inhibit CKG activity. In view of the possible inter- 
ference of the CKG system in vivo with the known 
cellular ~ycos~~o~y~s (GAG) [6] we decided 
to examine the interaction of available naturally- 
occurring GAG structures on 3 types of protein kin- 
ase activities using purified enzyme preparations. This 
EXwvierfNorth-Holland Biomedical Press 
paper eports the results obtained with 3 different 
protein kmases namely the catalytic subunit of 
CAMP-dependent PK and the bovine adrenal cortex 
casein kinases of the A- and G-types. Several naturally 
occuring GAG appear to selectively inhibit CK.G 
activity and may thus be proposed as useful biochem- 
ical tools for the characterization f cellular protein 
kinase activities. On the other hand, these observa- 
tions point to a possible role of proteoglycans as 
potential mod~ators of a specific protein kinase 
activity in intact cells. 
2. Materials and methods 
[Y~~P]ATP (20 Ci/mmol) was purchased from the 
Radiochemical Centre (Amersham). Casein (Merck) 
was treated according to 173 before use. Spermine 
(tetrahydrochloride), chondroitin sulfate A, B and C, 
hyaluronic acid (sodium salts) and histone (II A) were 
from Sigma. Heparin (sodium salt) was from Hoffman 
IaRoche. AG 50 W X 8 and AB 1 X 2 ionexchange 
resins were from Bio-Rad. 
2.1. Enzymatic preparations 
Casein klnase of the A (CKA)- and G (CKG)-types 
were isolated from bovine adrenal cortex cytosol 
after a stepwise lution from a phosphocellulose 
column in [4] with 0.6 and 1 M buffered NaCl, 
respectively. These preparations were stored at 
-20°C in TDG buffer (10 mM Tris-HCl @H 7.5) 
conta~ing 1 mM dit~ot~eitol, 2% glycerol and 1 mg 
bovine serum ~burn~~~~. Pure catalytic subunit (C) 
of bovine heart CAMP-de~ndent protein kinase was 
a generous gift from Professor J. Demaille 
(Montpellier). 
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2.2 , Protein kinme assay 3. Results 
This was performed under the incubation condi- 
tions in [8] with the t~~~oroacetic a id precipitation 
procedure of 191, as in [3--Q either with casein 
(with a 50 mM MgCIs final cont.) or histone (with a 
5 mM MgCls final cont.) as the substrate. Various 
amounts of model glycosaminoglycans were added 
to the assay, as indicated in the text and figure 
legends. Casein and histone kinase activity unit was 
defined as the amount of enzyme which catalysed the 
incorporation of 1 pmol 32P/min in *he protein sub- 
strate under the assay conditions. Inhibitory activities 
were quantitated by calculation of the 50% inhibitory 
dose @se) following the method in [IO]. 
3.1. Effect of various gly~osR~~~o~y~~n structures 
on G-type easein kinase activity (CKG] 
Fig.1 illustrates the effect of increasing concentra- 
tions of heparin, a chondroitin sulfate and hyaluronic 
acid on the activity of CKG isolated from bovine 
adrenal cortex cytosol. Heparin appeared to be a 
powerful inhibitor of CKG activity, being potent in 
the ng-range in the assay and yielding an almost com- 
plete inhibition of the enzyme for the highest concen- 
trations used. Hyaluronic acid was markedly less 
effective whereas chondroitin sulfates (A and B, not 
shown in fig.1) exhibited an Intermediate potency. 
The concentration of GAG needed to yield a 50% 
ambition of CKG under our assay conditions (fJ0) 
were: chondroitin sulfate A 325 r&ml; chondroitin 
sulfate B 350 &ml; chondroitin sulfate C 275 r&ml; 
heparin 94 ng/ml; hyaluronic acid 687 r&ml. 
2.3. Acid-base ti~~tion of g~y~os~~inogIycu~ 
Commercial GAG (sodium salts) and spermine 
(tetrahydrochloride) were desalted before titration by 
passage through an AG 50 W X 8 (hydrogen form), 
or an AC 1 X 2 (hydroxide form) ion-exchange r sin, 
respectively. GAG concentrations were determined as 
in [ 111 and spermine recovery was measured using 
[3H]spermine (New England Nuclear) added as tracer 
before ion-exchange treatment. Average recoveries 
were 60-80% for protonated GAG and 100% for 
tetr~ydroxylated spermine. Titration of protonated 
GAG (100 mg/ 10 ml) was performed either by 50 
mM NaOH or 15 mM spermine. Hyaluronic acid 
(0.5 mgjml) was titrated by 10 mM NaOH and 3 mM 
spermine solutions. 
Radioactive counting and all ancillary methods 
were as in [3-S]. 
Fig.1. Inhibition of G-type casein kinase activity by glycos- 
aminoglycan structures. The incubation conditions were as 
in section 2, in a fina 80 ~1 vol. containing casein (60 tigp), 
[-rs*P]ATP (lOeg M) and various amount of GAG in TDG 
buffer (SO mM MgCl,). The reaction was initiated by addi- 
tion of 10 units of purified adrenal cortex CKG. Each point 
is the mean of 3 replicates: HE, heparin; CSC, chondroitin 
sulfate C; HA, hyahuonic acid. 
3.2. Selectivity of CKG inhibition by various GAG 
Table 1 gives the results obtained when 3 different 
protein kinases (C, CKA, CKG) activities were 
Table 1 
Effect of several ~y~~rn~o~y~ and dextran sulfate on 
3 different protein kinases: C (catalytic subunit of the 
c~Pdepe~ent PK); CKA and CKG (casein kineses of the 
A- and G-types) 
Compound added Protein kinase act. 
(pm01 [ 32P]incorporated/min) 
C CKA CKG 
None (control) 62.1 1.1 10.0 (0) 
Heparin 3.1 ng 61.9 1.2 I .I (23) 
12.5 ng 62.0 1.1 3.3 (65) 
conjoin 
sulfate C 
3lng 62.5 1.0 2.7 (73) 
125 ng 62.3 0.9 1.6 (84) 
Hyahrronic acid 
31ng 61.8 0.9 4.4 (56) 
125 ng 62.1 1.1 2.6 (74) 
Dextran sulfate 
31ng 61.9 1.1 2.7 C73) 
125 ng 62.2 1.3 1.1 (89) 
Incubations were done as in section 2 either with histone 10 
OE casein (CL4 and CKG} as the substrate. hr parentheses: 5% 
inhibition with regard to the control 
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assayed in the absence or in the presence of various 
GAG at 2 different concentrations. The inhibitory 
effect appeared selectively directed toward CKG 
activity whereas Cand CKA were not affected, even 
at GAG concentrations which yielded 80-90% inhibi- 
tion of CKG. In addition to naturally occuring GAG 
structures, dextran sulfate was introduced in this 
study to check whether the polyanionic sulfate 
character was a common requirement for the inhib- 
itory activity. This sulfated polysaccharide was 
indeed a potent inhibitor of CKG, although -IO- 
times less active than heparin. The suggestion that a 
polyanionic structure may be required in the inhibi- 
tion process was further suggested by the lack of 
effect of characteristic monomeric GAG components 
such as glucuronic acid and glucosamine (not shown). 
3.3, Reversal of the GAG effect on CKG 
When an increasing amount of substrate (casein) 
was used in the assay of CKG in the presence of 
inhibitory doses of GAG, a progressive r lease of the 
inhibitory effect was observed, as i&&rated in table 
2. These data suggested that ~ycos~ino~yc~ struc- 
tures act through a com~titi~ inhibitory mechanism 
toward casein at the enzyme active site. 
Since the inhibitory activity appeared related to a 
negatively charged polymeric structure, the effect of 
naturally occuring polycations (namely polyamines) 
on the GAG inhibitory activity was examined. As 
illustrated in Bg.2, addition of increasing amounts of 
spermine to a glycosaminoglycan-inhibited CKG
resulted in a rapid release of inhibition in the case of 
heparin. However, spermine was not able to release 
the CKG i~bition due to the presence of chondroitin 
sulfate A, whereas the effect of C and B chondroit~ 
sulfates was only partly reversed by the polycation. 
It may thus be suggested that although common to 
Table 2 
Effect of substrate (casein) concentration on the inhibition 
of CKG activity (%) by different glycosaminoglycans 
GAG added CSA 
(&ml) (312.5) 
(Caseinj 
CSB csc HE HA 
(375) (312.5) (75) (1875) 
0.75 mg/ml 62 60 66 45 70 
7.5 mg/ml 5 4 8 4 7 
Assay conditions and abbreviations as in table 1. Each value 




Fig.2. Effect of a polyamine on the inhibition of CKG by 
various glycosaminoglycans. Casein kinase activity was mea- 
sured as in section 2 in the presence of 15 ng heparin 
(e-e), 200 ng chondroitin sulfate A (u-u) or 200 ng 
chondroitin sulfate C (o-o) in a standard reaction mixture 
(75 ~1) to which was added increasing amounts of spermine 
in 5 ~1 of 25 mM Tris-HC1 (pH 7.4) buffer. Each point is the 
mean of 3 replicates. 
all inhibitory GAG structures tested, the polysulfate 
character is not the unique molecular determinant 
for CKG inhibition. This point was further examined 
by acid-base titration of the glycosaminoglycans 
used. As shown in table 3, a good correlation was 
found for the acidic property of individual GAG 
titrated either by sodium hydroxide or spermine. 
However, although the most potent CKG inhibitor 
Table 3 
Acidic character and CKG ~bito~ potency of 
glycosaminoglycan structures 
GAG structure HE CSA csc HA 
NaOH titr. 
(mmol/g GAG) 8.15 4.46 5.2 5.06 
Spermine titr. 
(mmol/g GAG) 2.16 1.20 1.30 1.10 
NaOH 
spermine 3.71 3.72 4.03 4.62 
I,, for CKG 
(nglml) 94 325 215 687 
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(i.e., heparin) exhibited the highest acidic titer, there 
was no linear relationship between the acidic charac- 
ter as measured by these titration experiments and 
the CKG inhibitory potency (1se) in the case of chon- 
droitin sulfates and hyaluronic acid. It may thus be 
suggested that, although the polysulfate structure 
appears sufficient to selectively inhibit CKG activity, 
the overall inhibitory properties of naturally occuring 
GAG structures most likely involve additional and 
more specific molecular parameters. 
4. Discussion 
Naturally occuring glycosaminoglycan structures 
(e.g., heparin, chondroitin sulfates, hyaluronic acid) 
have been found to exhibit a selective inhibitory 
property directed toward G-type casein kinase activ- 
ity, whereas another casein kinase (CKA) and the 
CAMP-dependent protein kinase activities are not 
affected. This specific CKG inhibition can be reversed 
by an excess of protein substrate, suggesting that 
GAG act through a competitive mechanism. Polyca- 
tions such as naturally occuring polyamines (e.g., 
spermine) are able to release the GAG effect on CKG 
activity, although this does not appear a general 
property for all GAG examined in this study. These 
observations suggest hat the active site of CKG is 
specifically sensitive to polyanionic structures such as 
polysulfated polysaccharides. This is especially true of 
heparin, which specifically inhibits CKG activity at 
low concentration and whose action can be fully 
reversed upon polyamine addition. These properties 
toward CKG are reminiscent of what had been found 
with a specific endogenous inhibitor of CKG (CKG I) 
purified from adrenal cortex cytosol [3--S]. Current 
work is in progress toward the structural identifica- 
tion of CKG I, which appears also as a negatively 
charged moiety [3-51, unpublished). With regard to 
the biological significance of the findings reported 
herein, it remains to be established whether glyco- 
saminoglycans and particularly heparin could be 
potent modulators of CKG activity in the intact cell. 
Many pharmacological properties of GAG have been 
reported in vivo [ 121 and interaction of these poly- 
anions with several cellular enzymatic systems have 
been described [ 131. Although a scanty knowledge of 
GAG intracellular distribution is available [ 131, these 
structures appear not only attached to plasma mem- 
branes [ 13,141 but have been found associated with 
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intracellular components [13-151. On the other 
hand, due to their marked and specific inhibitory 
action on CKG activity GAG may be proposed as a 
useful biochemical tool in the characterization of 
various types of protein kinase activities in mammalian 
tissues. 
Further studies are needed along these lines to 
define a possible relationship between CKG activity 
(and thus intracellular protein phosphorylations) and 
glycosaminoglycans. This would also help to define 
the possible role of CKG in the cellular functions 
since both qualitative and quantitative variations of 
GAG cellular content have been suggested to be 
related to normal and pathological cellular prolifer- 
ating activity [12,13]. 
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